| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f56d58e8a120d04e8619b0500a02bdd5 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437 |
| filingDate |
2017-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a67fd52af827c6ab3fe508b90dec995
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc11f43d9f78af92a49f8218ea0b3b1f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1a69e2bc6ee11ea0b04821364bf65b3 |
| publicationDate |
2018-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20180056366-A |
| titleOfInvention |
Pharmaceutical compositions comprising tubulosine for preventing or treating cancers |
| abstract |
The present invention relates to a pharmaceutical composition for treating cancer comprising tubulosine as an active ingredient. In the compositions of the present invention, Tubulosin strongly inhibits both structurally activated cytokine-induced JAK3 signaling by inhibiting the activity of JAK catalysis in leukemia and lymphoma cell lines, resulting in the survival and proliferation of active JAK-mediated cancer cells And the like. |
| priorityDate |
2016-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |